Recruiting Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) NCT07197307 Conditions Aggressive Diffuse Large B-cell Lymphoma, Follicular Lymphoma (FL) Grade 3B, Hemic and Lymphatic Diseases, +12 more Locations Universitätsklinikum Münster, Medizinische Klinik A — Münster, Germany Universitaetsklinikum Aachen — Aachen, Germany Universitaetsklinikum Augsburg — Augsburg, Germany Vivantes Netzwerk fuer Gesundheit — Berlin, Germany View all 34 locations View more locations Show fewer locations Loading locations... View Trial Details
